It is reported that Akt and ERK signaling are dysregulated or mutated in human cancers, including bladder cancer (Koboldt et al., 2012; Calderaro et al., 2014; Tan et al., 2019). This evidence concerns the gene AKT1 and urinary bladder cancer.